Wed, February 3, 2016
Tue, February 2, 2016
Mon, February 1, 2016
Fri, January 29, 2016
Thu, January 28, 2016
Wed, January 27, 2016
Tue, January 26, 2016
Mon, January 25, 2016
Fri, January 22, 2016
Thu, January 21, 2016
Wed, January 20, 2016
Tue, January 19, 2016
Fri, January 15, 2016
Thu, January 14, 2016
Wed, January 13, 2016
Tue, January 12, 2016
Mon, January 11, 2016
Sun, January 10, 2016
Fri, January 8, 2016
Thu, January 7, 2016
Wed, January 6, 2016
Tue, January 5, 2016
Mon, January 4, 2016

Evan Seigerman Initiated (BIIB) at Hold and Held Target at $322 on, Jan 20th, 2016


//stocks-investing.news-articles.net/content/201 .. old-and-held-target-at-322-on-jan-20th-2016.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation



Evan Seigerman of Credit Suisse, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $322 on, Jan 20th, 2016.

Evan has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Evan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Evan


  • Steve Chesney of "Atlantic Equities" Initiated at Buy and Held Target at $344 on, Friday, December 18th, 2015
  • Mohit Bansal of "Wells Fargo" Initiated at Buy on, Friday, December 4th, 2015
  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy on, Thursday, November 5th, 2015

Publication Contributing Sources